Morgan Stanley’s New Frontier Health Corporation Ordinary Shares NFH Stock Holding History

Morgan Stanley’s Portfolio NFH Stock Details NFH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,047,758	Closed	-$46.4M	–	8381
2021 Q4	$46.4M	Buy	4,047,758 +43,957	+1%	+$496K	0.01%	1390
2021 Q3	$45M	Sell	4,003,801 -24,085	-0.6%	-$268K	0.01%	1373
2021 Q2	$45M	Buy	4,027,886 +23,515	+0.6%	+$264K	0.01%	1396
2021 Q1	$45.3M	Sell	4,004,371 -169,217	-4%	-$1.72M	0.01%	1236
2020 Q4	$35.9M	Buy	4,173,588 +137,334	+3%	+$1.18M	0.01%	1340
2020 Q3	$30.8M	Buy	4,036,254 +8,353	+0.2%	+$68.5K	0.01%	1174
2020 Q2	$33.4M	Buy	4,027,901 +25,463	+0.6%	+$207K	0.01%	1079
2020 Q1	$33M	Buy	4,002,438 +3,992,479	+40,089%	+$36.3M	0.01%	964
2019 Q4	$100K	Buy	+9,959	New	+$102K	﹤0.01%	5656

Other funds holding NFH

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Morgan Stanley's NFH Position: Q1 2022 in Review

Morgan Stanley sold out of New Frontier Health Corporation Ordinary Shares (NFH) in Q1 2022, closing a stake of 4,047,758 shares — an estimated $46.4M sold.

Morgan Stanley first reported a position in NFH in Q4 2019 and held it in 9 quarters. The position peaked at $46.4M in Q4 2021. 2 funds tracked by Wall St. Rank hold NFH as of Q1 2022.

Morgan Stanley reported no remaining New Frontier Health Corporation Ordinary Shares position as of Q1 2022 after selling out during the quarter.
Morgan Stanley sold 4,047,758 New Frontier Health Corporation Ordinary Shares shares in Q1 2022, an estimated $46.4M.
Morgan Stanley first reported a position in New Frontier Health Corporation Ordinary Shares in Q4 2019 and held it in 9 quarters.
Morgan Stanley's New Frontier Health Corporation Ordinary Shares position peaked at $46.4M in Q4 2021.
2 funds tracked by Wall St. Rank held New Frontier Health Corporation Ordinary Shares as of Q1 2022.

Based on Morgan Stanley's 13F filing for Q1 2022, filed 13 May 2022.